Quality of life of GIST patients with and without current tyrosine kinase inhibitor treatment: Cross-sectional results of a German multicentre observational study (PROSa).

Martin EichlerDaniel PinkFranka MengeJens JakobLeopold HentschelStephan RichterPeter HohenbergerBernd KasperDimosthenis AndreouSusanne SingerRobert GrützmannDiana I DmytrowKarin ArndtArmin TuchschererPeter ReichardtMarit AhrensAnnegret KunitzJohannes MohmMartin BornhäuserJochen SchmittMarkus K Schuler

Published in: European journal of cancer care (2021)

The highest HRQoL restrictions were in GIST patients receiving multiple lines of TKI therapy. Underlying causes need further investigation.

Keyphrases

cross sectional
clinical trial
tyrosine kinase
study protocol
stem cells
randomized controlled trial
combination therapy
replacement therapy